Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
ADVANCED SEARCH
Log in
Top
BMC Neurology
Published in:

Open Access 01-12-2024 | Long-COVID Syndrome | Research

Cognitive impact and brain structural changes in long COVID patients: a cross-sectional MRI study two years post infection in a cohort from Argentina

Authors: Sol A. Cataldo, Andrea Micciulli, Laura Margulis, Melina Cibeyra, Sabrina Defeo, Silvina G. Horovitz, Analía Martino, Raul Melano, Milagros Mena, Francisco Parisi, Diego Santoro, Florencia Sarmiento, Martin A. Belzunce

Published in: BMC Neurology | Issue 1/2024

Login to get access

Abstract

Objective

Long COVID is a condition characterised by persistent symptoms after a SARS-CoV-2 infection, with neurological manifestations being particularly frequent. Existing research suggests that long COVID patients not only report cognitive symptoms but also exhibit measurable cognitive impairment. Neuroimaging studies have identified structural alterations in brain regions linked to cognitive functions. However, most of these studies have focused on patients within months of their initial infection. This study aims to explore the longer-term cognitive effects and brain structural changes in long COVID patients, approximately two years post-infection, in a cohort from San Martín, Buenos Aires, Argentina.

Methods

We conducted a cross-sectional study involving 137 participants: 109 with long COVID symptoms and 28 healthy controls. The participants underwent an initial clinical assessment, completed a structured questionnaire and standardised scales, underwent a cognitive assessment, and had a brain MRI scan. Structural MRI images were processed via FreeSurfer and FSL to obtain volumetric measures for subcortical and cortical regions, along with regional cortical thickness. Differences between groups for these variables were analysed using ANCOVA, with permutation tests applied to correct for multiple comparisons.

Results

Long COVID patients reported persistent cognitive symptoms such as memory problems and brain fog, with higher levels of fatigue and reduced quality of life compared to controls. Despite subjective cognitive complaints, cognitive tests did not reveal significant differences between groups, except for the TMT-A (p = 0.05). MRI analysis revealed decreased volume in the cerebellum (p = 0.03), lingual gyrus (p = 0.04), and inferior parietal regions (p = 0.03), and reduced cortical thickness in several areas, including the left and right postcentral gyri (p = 0.02, p = 0.03) and precuneus (p = 0.01, p = 0.02).

Conclusions

This study highlights the enduring impact of long COVID on quality of life and physical activity, with specific brain structural changes identified two years post-infection. Although cognitive tests did not show clear impairment, the observed brain atrophy and significant reduction in quality of life emphasize the need for comprehensive interventions and further longitudinal studies to understand the long-term effects of long COVID on cognition and brain health.
Appendix
Available only for authorised users
Literature
1.
2.
Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022 287 28, 1461–1467 (2022).
3.
Ayoubkhani D et al. Risk of long COVID in people infected with severe Acute Respiratory Syndrome Coronavirus 2 after 2 doses of a Coronavirus Disease 2019 Vaccine: Community-Based, matched Cohort Study. Open Forum Infect Dis 9, (2022).
4.
Subramanian A et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022 288 28, 1706–1714 (2022).
5.
6.
Michelen M, et al. Characterising long COVID: a living systematic review. BMJ Glob Heal. 2021;6:e005427.CrossRef
7.
Ladds E, et al. Persistent symptoms after Covid-19: qualitative study of 114 long Covid patients and draft quality principles for services. BMC Health Serv Res. 2020;20:1–13.CrossRef
8.
9.
Mazza MG, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138–47.CrossRefPubMedCentralPubMed
10.
Woo MS et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun 2, (2020).
11.
12.
13.
14.
Meinhardt J et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2020 242 24, 168–175 (2020).
15.
16.
Song E et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 218, (2021).
17.
Greene C, et al. Blood–brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024;273(27):421–32. (2024).CrossRef
18.
Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer’s Res Ther. 2020;12:1–3.
19.
Zorzo C, Solares L, Mendez M, Mendez-Lopez M. Hippocampal alterations after SARS-CoV-2 infection: a systematic review. Behav Brain Res. 2023;455:114662.CrossRefPubMed
20.
21.
Díez-Cirarda M, et al. Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome. eBioMedicine. 2023;94:104711.CrossRefPubMedCentralPubMed
22.
23.
24.
Grobbelaar LM et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci Rep 41, (2021).
25.
26.
27.
28.
Nabizadeh F, et al. Neuroimaging findings of COVID-19: a systematic review on longitudinal studies. Neurol Lett. 2024;3:27–36.CrossRef
29.
Rothstein TL. Cortical Grey matter volume depletion links to neurological sequelae in post COVID-19 long haulers. BMC Neurol. 2023;23:1–11.CrossRef
30.
Lu Y, et al. Cerebral micro-structural changes in COVID-19 patients – an MRI-based 3-month follow-up study: a brief title: cerebral changes in COVID-19. EClinicalMedicine. 2020;25:100484.CrossRefPubMedCentralPubMed
31.
32.
33.
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213.CrossRefPubMed
34.
Craig CL, et al. International physical activity questionnaire: 12-Country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–95.CrossRefPubMed
35.
36.
37.
Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol. 1955;19:393–4.CrossRefPubMed
38.
Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643–62.CrossRef
39.
Wechsler DWMS-R. Wechsler Memory Scale–Revised: manual. 150 (1987).
40.
Nasreddine ZS, et al. The Montreal Cognitive Assessment, MoCA: a brief Screening Tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.CrossRefPubMed
41.
Margulis LE, Louhau S, M. R., Ferreres AR. Baremo Del Trail making test para Capital Federal Y Gran Buenos Aires. Rev Argent Cienc Comport. 2018;10:54–63.
42.
Rivera D, et al. Stroop Color-Word interference test: normative data for the latin American Spanish speaking adult population. NeuroRehabilitation. 2015;37:591–624.CrossRefPubMed
43.
Cervigni M, Martino P, Alfonso G, Politis D. Montreal Cognitive Assessment (MoCA): normas para la población del área metropolitana de Rosario, Argentina. Rev Neurol. 2022;75:51.PubMedCentralPubMed
44.
Smith SM, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage. 2002;17:479–89.CrossRefPubMed
45.
Smith SM et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23 Suppl 1, (2004).
46.
Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. 97, 11050–11055 (2000).
47.
Fischl B, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341–55.CrossRefPubMed
48.
Fischl B et al. Sequence-independent segmentation of magnetic resonance images. NeuroImage 23 Suppl 1, (2004).
49.
Westfall PH, Young SS. Resampling-based multiple testing: examples and methods for P-value adjustment. New York, John Wiley & Sons; 1993.
50.
Del Brutto OH, Rumbea DA, Recalde BY, Mera RM. Cognitive sequelae of long COVID may not be permanent: a prospective study. Eur J Neurol. 2022;29:1218–21.CrossRefPubMed
51.
52.
53.
Walitt B et al. Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome. Nat Commun 15, (2024).
54.
Komaroff AL, Lipkin WI. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med. 2023;10:1187163.CrossRef
55.
Du Y, et al. Two-year follow-up of brain structural changes in patients who recovered from COVID-19: a prospective study. Psychiatry Res. 2023;319:114969.CrossRefPubMed
56.
57.
Beuriat PA, Cristofori I, Gordon B, Grafman J. The shifting role of the cerebellum in executive, emotional and social processing across the lifespan. Behav Brain Funct. 2022;18:1–11.CrossRef
58.
Yokoi T et al. Involvement of the Precuneus/Posterior cingulate cortex is significant for the development of Alzheimer’s Disease: a PET (THK5351, PiB) and resting fMRI study. Front Aging Neurosci. 10, (2018).
59.
Karas G, et al. Precuneus atrophy in early-onset Alzheimer’s disease: a morphometric structural MRI study. Neuroradiology. 2007;49:967–76.CrossRefPubMed
60.
Gazzaniga MS, Ivry RB, Mangun GR. Cognitive neuroscience: the biology of the mind. 2nd ed. W. W. Norton: New York, NY, USA; 2002.
Metadata
Title
Cognitive impact and brain structural changes in long COVID patients: a cross-sectional MRI study two years post infection in a cohort from Argentina
Authors
Sol A. Cataldo
Andrea Micciulli
Laura Margulis
Melina Cibeyra
Sabrina Defeo
Silvina G. Horovitz
Analía Martino
Raul Melano
Milagros Mena
Francisco Parisi
Diego Santoro
Florencia Sarmiento
Martin A. Belzunce
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2024
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-024-03959-8

Other articles of this Issue 1/2024

Designing and validating of a questionnaire measuring perceived self-care ability (PSCA) in chronic stroke patients at home

Pharmacological and physiological effects of cannabidiol: a dose escalation, placebo washout study protocol

Optimizing electroencephalogram duration for efficient detection of epileptiform abnormalities in diverse patient groups: a retrospective study

Predicting who has delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage using machine learning approach: a multicenter, retrospective cohort study

Adult-onset combined oxidative phosphorylation deficiency type 14 manifests as epileptic status: a new phenotype and literature review

Amyotrophic lateral sclerosis associated with Sjögren’s syndrome: a case report